Fusion Proteins
Reports outline fusion proteins research from Royal Free and University College
Published in Medical Imaging Week, January 20th, 2007
A report, "Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy," is newly published data in Glycobiology. According to recent research from London, the United Kingdom, "MFECP1 is a mannosylated antibody-enzyme fusion protein used in antibody-directed enzyme prodrug therapy (ADEPT). The antibody selectively targets tumor cells and the targeted enzyme converts a prodrug into a toxic drug."
"MFECP1 is obtained from expression in the yeast Pichia pastoris and produced to clinical grade. The P. pastoris-derived mannosylation of the fusion protein aids rapid normal tissue clearance required for successful ADEPT. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2007-01-20)
More Articles from Medical Imaging Week
- Breast Cancer Genetics
Studies from Antoni van Leeuwenhoek Hospital, Department of Surgery add new findings in the area of breast cancer genetics - Breast Cancer Screening
Research from University Hospital provide new insights into breast cancer screening - Breast Cancer Screening Prevention
New breast cancer screening prevention research has been reported by scientists at University of Kent, Department of Psychology - Ductal Carcinoma in Situ
Research from University of Nottingham has provided new information about ductal carcinoma in situ - Alcoholism Prevention
Researchers from University of Cape Town, Department of Surgery publish new studies and findings in the area of alcoholism prevention - Alzheimer Disease Pathology
Researchers from University of California, Semel Institute for Neuroscience and Human Behavior detail new studies and findings in the area of alzheimer disease pathology - More from this issue of Medical Imaging Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
